Thanks to community partnerships and hundreds of cyclists, a laboratory scientist at the Georgia Cancer Center is making a difference in the fight against liver cancer.
A research team led by Augusta University Executive Vice President for Academic Affairs and Provost Neil J. MacKinnon, PhD, has authored a new study that looks at geographic health disparities in 11 high-income countries.
It is a key to life, but not every person living in Augusta has the same access to healthy food as their neighbors across the region.
Telehealth has seen a surge in popularity in recent years, but the challenge comes when patients don't have access to high-speed internet. A new study co-authored by Neil J. MacKinnon, PhD, looks at the digital divide and how it intersects with...
A study conducted by a team of researchers from the Dental College of Georgia at Augusta University tested inhalant CBD in the treatment of lung cancer and whether it could inhibit tumors from growing or spreading.
Targeting that receptor could provide earlier, more impactful treatments for retinopathy of prematurity.
Retinopathy of prematurity (ROP) is among the most common illnesses that affect premature or low birth-weight infants and is a major cause of long-term vision impairment and blindness.
Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.
Patients come to Amol Sharma, MD, because their stomachs constantly hurt, they are always nauseous and they can’t or won’t eat or drink
The drugs are called HDAC inhibitors, and the investigators have early evidence one can reactivate after birth the gene that produces fetal hemoglobin, which cannot sickle.
Without CARMN, a long, noncoding RNA, the 30-foot-long GI tract doesn’t contract as it should.
MicroRNAs help regulate gene expression and consequently the function of our cells, and several, including one called microRNA-141-3p, have been implicated in the ills of aging.
The University System of Georgia Board of Regents recently approved David C. Hess, MD, David Munn, MD, and Babak Baban, PhD, as the first three Augusta University faculty researchers to be named Regents’ Entrepreneurs for their success in...
Insomnia affects up to half of people with schizophrenia and is thought to worsen the impact of their disease, including their risk of suicide. A new meta-analysis of the antipsychotics these patients take indicates those who take clozapine have...
Neil J. MacKinnon, PhD, provost and executive vice president for academic affairs at Augusta University, and Zach Kelehear, EdD, vice provost for instruction, announced this week that four collaborative research projects stemming from the Converge...
The first in-human study of a new immunotherapy that blocks a natural enzyme that tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life...
With preterm birth, the still-immature retina can develop a potentially blinding eye disorder known as retinopathy of prematurity.
A new $2.3 million grant from the National Cancer Institute is giving the Georgia Cancer Center the opportunity to understand how those cancer cells resist primary treatment and propose new treatment options that may improve patient survival.
The new IMMCG focuses on better understanding the immune system’s seemingly diametric roles in enabling good health and in contributing to major killers.
The discovery may help explain why sometimes promising immunotherapies designed to help the immune system kill cancer don’t.

